Other OTC - Delayed Quote USD

AppYea, Inc. (APYP)

0.0226 +0.0007 (+3.24%)
At close: May 14 at 2:41 PM EDT
Loading Chart for APYP
DELL
  • Previous Close 0.0219
  • Open 0.0219
  • Bid --
  • Ask --
  • Day's Range 0.0190 - 0.0226
  • 52 Week Range 0.0030 - 0.1700
  • Volume 89,644
  • Avg. Volume 88,650
  • Market Cap (intraday) 9.417M
  • Beta (5Y Monthly) -0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date May 15, 2024 - May 19, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. It develops AppySleep app, a wristband that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns in the sleep and identify sleep arena episode without direct contact to the user; and AppySleep PRO a wristband for the treatment of sleep arena using biofeedback in combination with AppySleep LAB app. The company was founded in 2012 and is based in Gan Yavne, Israel.

www.appyea.com

9

Full Time Employees

December 31

Fiscal Year Ends

Recent News: APYP

Performance Overview: APYP

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

APYP
50.67%
S&P 500
10.00%

1-Year Return

APYP
50.67%
S&P 500
27.22%

3-Year Return

APYP
94.05%
S&P 500
27.58%

5-Year Return

APYP
13.00%
S&P 500
86.59%

Compare To: APYP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: APYP

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    9.12M

  • Enterprise Value

    10.98M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -301.55%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.82M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    222k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -90.38k

Research Analysis: APYP

Company Insights: APYP

Research Reports: APYP

People Also Watch